Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab.
| Last: | $1.56 |
|---|---|
| Change Percent: | -5.45% |
| Open: | $1.61 |
| Close: | $1.65 |
| High: | $1.64 |
| Low: | $1.5495 |
| Volume: | 13,820 |
| Last Trade Date Time: | 03/06/2026 12:31:29 pm |
| Market Cap: | $15,422,373 |
|---|---|
| Float: | 6,872,146 |
| Insiders Ownership: | 2.64% |
| Institutions: | 11 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.trawspharma.com |
| Country: | US |
| City: | Newtown |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Traws Pharma Inc. (NASDAQ: TRAW).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
